Magnetic Resonance Imaging in Metabolic Diseases

University of Ulm126 enrolled

Overview

This study aims to leverage structural, functional, and metabolic magnetic resonance imaging (MRI) of the brain to identify imaging features that correlate with clinical parameters. It is hypothesized that individuals with metabolic diseases exhibit distinct functional and structural brain differences compared to healthy controls. These differences may evolve over time due to changes in whole-body metabolism or body weight, influenced by factors such as the natural progression of the disease or therapeutic interventions. Additionally, potential brain changes may correlate with body composition metrics, such as the fat content of specific body compartments. This is a prospective, single-center study conducted at Ulm University Hospital, designed to track the clinical and imaging histories of patients with metabolic diseases and compare them to healthy individuals. Eligible participants include adults (aged 18 and older) capable of providing informed consent. Recruitment will occur through routine clinical care or existing research studies. To provide a comprehensive understanding, the study will include both cross-sectional analyses and longitudinal follow-up of participants, integrating repeated assessments during routine medical visits.

Study Type

OBSERVATIONAL

Enrollment

126

Conditions

Metabolic Diseases

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients with metabolic diseases OR * healthy control participants without metabolic diseases * written consent Exclusion Criteria: * History of traumatic brain injuries * preterm birth (≤34th week of pregnancy) of the study participant * history of brain surgery * structural brain changes (e.g., tumors, congenital abnormalities, etc.) * neurological developmental disorders (e.g., autism spectrum disorders, learning disabilities, intellectual disability) * epilepsy, * drug addiction * other severe neurological or severe psychiatric disorders (e.g., schizophrenia * pregnancy * acute clinically relevant inflammatory diseases * acute systemic or local infections * severe or etiologically unclear diseases depending on the principle investigators judgement * pre-existing intellectual impairment * significant limitations in language comprehension * absence of written consent * general exclusion criteria for MRI imaging (e.g., pacemaker systems, neurostimulators, cochlear implants)

Outcomes

Primary Outcomes

Structural differences in the brain between patients with metabolic diseases and healthy controls

Comparison of brain anatomical magnetic resonance imaging sequences (T1- and T2-weighted sequences) between patients with metabolic diseases and healthy controls give insights into structural features in patients with metabolic diseases.

Time frame: cross-sectional and up to 5 years, depending on regular visits as part of routine patient care that, however, are not part of this scientific project.

Functional differences in the brain between patients with metabolic diseases and healthy controls

Comparison of brain functional magnetic resonance imaging between patients with metabolic diseases and healthy controls will give insights into functional aspects of patients with metabolic diseases.

Time frame: cross-sectional and up to 5 years, depending on regular visits as part of routine patient care that, however, are not part of this scientific project.

Metabolic differences in the brain between patients with metabolic diseases and healthy controls

Comparison of brain metabolic magnetic resonance imaging (Chemical Exchange Saturation Transfer (CEST)", MR-spectroscopy) between patients with metabolic diseases and healthy controls give insights into metabolic features in patients with metabolic diseases

Time frame: cross-sectional and up to 5 years, depending on regular visits as part of routine patient care that, however, are not part of this scientific project.

Body Composition derived from magnetic resonance imaging

Magnetic resonance imaging (DIXON sequence or fat-water imaging to determine the "Proton Density Fat Fraction" (PDFF)) will be used to determine the fat content in the different compartments of the whole body.

Time frame: cross-sectional and up to 5 years, depending on regular visits as part of routine patient care that, however, are not part of this scientific project.

Magnetic Resonance Imaging in Metabolic Diseases

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Central Contacts